The second most frequent disorder in HCC is mutations in the tumor suppressor gene TP53 [61], some mutations of which contribute to the emergence of the pro-oncogenic function of the encoded protein p53—increased cell proliferation, drug resistance, and increased migration and invasion of cells, as well as the stimulation of neoangiogenesis [62,63]. This evidence concerns the gene TP53 and hepatocellular carcinoma.